India needs to offer tax incentives, push health startups to make country global medical hub: Report
needs to offer
tax incentives for hospitals
treating international patients and promote startups in the health sector to make the country a global medical hub by 2035, said a report.
The 'Heal in India: Catalysing Medical and Wellness Tourism for a Healthier Global Future' report, released on Thursday, said that India's medical tourism market is expected to increase from USD 18.2 billion in 2025 to USD 58.2 billion by 2035, growing at an annual compounded rate of 12.3 per cent.
Explore courses from Top Institutes in
Select a Course Category
Data Science
Healthcare
CXO
Data Science
MCA
others
Design Thinking
Data Analytics
Operations Management
Cybersecurity
Others
Degree
Technology
Product Management
Leadership
Project Management
healthcare
Management
MBA
Public Policy
PGDM
Finance
Digital Marketing
Artificial Intelligence
Skills you'll gain:
Duration:
11 Months
IIT Madras
CERT-IITM Advanced Cert Prog in AI and ML India
Starts on
undefined
Get Details
Skills you'll gain:
Duration:
30 Weeks
IIM Kozhikode
SEPO - IIMK-AI for Senior Executives India
Starts on
undefined
Get Details
Skills you'll gain:
Duration:
11 Months
E&ICT Academy, Indian Institute of Technology Guwahati
CERT-IITG Postgraduate Cert in AI and ML India
Starts on
undefined
Get Details
Skills you'll gain:
Duration:
10 Months
IIM Kozhikode
CERT-IIMK DABS India
Starts on
undefined
Get Details
Skills you'll gain:
Duration:
10 Months
E&ICT Academy, Indian Institute of Technology Guwahati
CERT-IITG Prof Cert in DS & BA with GenAI India
Starts on
undefined
Get Details
The report launched by Federation of Hotel and Restaurant Associations of India (FHRAI), in collaboration with KPMG in India, also recommended the introduction of global branding campaigns by leveraging embassies, expos, and digital platforms and the launch of 'Heal in India' missions at the national and state levels.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Struggling With Belly Fat? Try This at Home
Home Fitness Hack
Shop Now
Undo
"To attract investment and improve service delivery, India should offer a mix of fiscal and non-fiscal incentives. These include tax exemptions for hospitals treating international patients, increased subsidies under the Marketing Development Assistance scheme, technical support for marketing and promotion, including on digital platforms, and 100 per cent FDI in broader medical infrastructure, including wellness centres," the report stated.
It further called for the introduction of targeted subsidies and grants for startups and organisations working in health-tech, medical research, and digital health solutions that directly support medical tourism.
Live Events
Notably, recommends enabling insurance portability by collaborating with international insurance providers to include Indian hospitals in their coverage networks, arguing that this could reduce financial barriers for foreign patients and make India a more viable destination for insured medical travellers.
The report also suggests addressing gaps in visa-insurance linkage, strengthening capacity building by training health facilitators and providers on global standards and multi-lingual hospitality.
"To reinforce India's leadership in global medical and wellness tourism, a structured mission should be initiated at both national and state levels, aligned with the National Strategy and Roadmap for Medical and Wellness Tourism," the report stated.
It recommended elevating the existing National Medical and Wellness Tourism Promotion Board into a comprehensive national mission that facilitates strategic policy execution and inter-ministerial coordination.
India ranks 10th in the Medical Tourism Index and 7th in Wellness Tourism, attracting nearly 2 million international patients from 75 countries.
Medical visa issuance by India rose to 4,63,725 in 2024, with the majority of patients from Bangladesh, GCC nations, and Africa.
The global medical tourism market, pegged at USD 41.75 billion in 2024, and wellness tourism (at USD 954.14 billion), are expected to double by 2030 and 2034, respectively.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
33 minutes ago
- Indian Express
IVF and gender bias: Why are we still choosing boys?
Dr Rhythm Bhalla A well-off, educated couple from Canada walked into my clinic last week, seeking consultation for in-vitro fertilization (IVF). 'After ten years of marriage, we've been yearning for a child and would value your guidance,' the wife said. It was a standard conversation—until she quietly added, 'I would like a male child.' Her husband, though slightly hesitant, nodded in agreement. As a gynecologist, such requests are, unfortunately, not rare. IVF, while a medical marvel offering hope to countless childless couples, has also opened the door to something far more problematic: sex selection. It prompts a painful question—why this persistent preference for boys? From the operating table to the boardroom, women have proved themselves over and over. Whether it is medicine, law, aviation, science, or governance, women are thriving. They run countries, lead corporations, and redefine success across every domain. Yet, a slice of society continues to believe that a male child holds higher value—a belief not just outdated but dangerous. In the Indian context, this preference has deep cultural roots. Traditionally, lineage and inheritance have been perceived as the domain of the male child. Whether it's lighting the funeral pyre or passing down the family name and business, the responsibility has always been reserved for sons. 'A father cannot exist without a mother,' I remind my patients, yet many still hesitate to envision a daughter performing these roles. Underpinning these decisions are centuries-old expectations and pressures. Indian women are often burdened—silently or overtly—with the expectation of giving birth to a boy. I've seen couples devastated by the birth of a second girl. I've met women emotionally blackmailed—threatened with abandonment or divorce—because they failed to provide a 'male heir.' And I've had educated, affluent couples ask for male sex selection in IVF simply to appease family elders with ideas of inheritance and legacy. To such couples, I ask: Why not a girl? Can't she lead your legacy, inherit your business, care for aging parents, and bring the same joy, prosperity, and pride? Yet, most often, my questions are met with awkward chuckles and patronizing smiles. We remain shackled by beliefs that a male child is central to carrying forward the family line—beliefs that desperately need to change. Denied legal sex selection in India, many such couples head to international clinics in Dubai, Thailand, or Singapore, where the practice is not illegal, thus legitimizing their biased preferences. But regardless of venue or legality, the problematic sentiment remains the same. Here in India, our laws are clear. The Pre-Conception and Pre-Natal Diagnostic Techniques (PCPNDT) Act, amended in 2003, strictly prohibits sex selection before or after conception. While illegal centers do continue to operate, the government has intensified scrutiny to curb this menace. However, this vigilance, while necessary, often leads to undue pressure on ethical doctors and innocent couples navigating the IVF journey the right way. Beyond legal enforcement, however, we must shift mindsets. Education and public awareness campaigns should aim to dismantle these damaging beliefs. Legal reform alone won't suffice; societal expectations, especially those that quietly coerce women into choosing male offspring, must be publicly challenged. Empowering women economically can create ripples of change. IVF may be a gift of science, but how we choose to use it reveals who we are as a society. Until every child, regardless of gender, is equally welcomed and celebrated, the work remains unfinished. (The writer is Dr. Rhythm Bhalla is a senior gynaecologist based in Chandigarh)
The Hindu
33 minutes ago
- The Hindu
Study alleging widespread antibiotic contamination in Indian rivers based on assumptions: Govt
A recent study alleging widespread antibiotic contamination in Indian rivers is based on "simulations and assumptions" and therefore, no conclusion on the issue can be drawn from it, the government has said. Replying to a question by Congress MP Pramod Tiwari in the Rajya Sabha on Friday, Union Minister of State for Environment Kirti Vardhan Singh said the study has cited its "own limitations of data availability". Study findings The study, conducted by researchers from McGill University, alleged that 80 per cent of the total length of rivers in India could be posing environmental and health risks due to antibiotic pollution. The media report, published on April 24, 2025, is based on a study titled 'Antibiotics in the global river system arising from human consumption' conducted by researchers from McGill University, Canada, and its "findings are based on simulations and assumptions", the minister said in a written reply. Furthermore, the minister informed that the government has not conducted any study on antibiotic contamination of rivers. Regarding the steps taken to regulate pharmaceutical waste and strengthen pollution control, Singh informed that the government launched the National Action Plan on Antimicrobial Resistance (NAP-AMR) in April 2017 to develop and implement strategic interventions to reduce the environmental impact of antimicrobial resistance through effective waste management and safe disposal of expired antimicrobials. He mentioned that the environment ministry issued a notification for the bulk drug and pharmaceutical industry in August 2021, classifying chemical and biological sludge or any residue generated from wastewater treatment as hazardous waste. These shall be managed in an environmentally sound manner in accordance with the Hazardous Waste and Other Wastes (Management and Transboundary Movement) Rules, 2016, Singh added. He highlighted that state pollution control boards have been empowered to prescribe additional relevant parameters and monitoring frequencies based on local conditions. The expired antimicrobials are disposed of by manufacturers or suppliers through incineration as per the Bio-medical Waste Management Rules, 2016, while sludge from effluent treatment plants is sent to common biomedical or hazardous waste treatment facilities for incineration or safe disposal. "To reduce antibiotic residue from effluent sources, industries are adopting reduce, recycle and reuse of treated effluent to maximise the extent of Zero Liquid Discharge to minimise the risk of pharmaceutical compound residues," the minister said.
Hans India
2 hours ago
- Hans India
Manipal Hospitals seeks CCI nod to acquire Sahyadri Hospitals for about Rs 6,400 cr
Healthcare major Manipal Hospitals has sought approval from the fair trade regulator CCI to acquire Pune-based Sahyadri Hospitals from global investor Ontario Teachers' Pension Plan Board in a deal pegged at around Rs 6,400 crore. The companies did not share the deal size, but industry sources estimate the transaction to be in the range of Rs 6,200-6,400 crore. "The proposed transaction envisages the acquisition of up to 100 per cent shareholding by the acquirer (Manipal Hospitals Pvt Ltd) in the target (Sahyadri Hospitals Pvt Ltd) in multiple tranches," according to a notice filed with the Competition Commission of India (CCI). Manipal Hospitals and Sahyadri Hospitals said the "proposed transaction does not have any impact on any relevant market in India, let alone any appreciable adverse effect on competition (AAEC), and therefore, the definition of the relevant product and geographic market may ultimately be left open. In any event, in order to aid and assist the CCI in its assessment". Last month, Manipal Hospitals announced that it had inked definitive agreements with Ontario Teachers' for the acquisition. The Bengaluru-based healthcare major said the acquisition of Sahyadri Hospitals will bring Manipal's total bed count to about 12,000, making it one of India's largest hospital networks. The acquisition will add 11 hospitals to Manipal's network across Pune, Nashik, Ahilya Nagar and Karad, increasing its total number of hospitals to 49, it added. Through this acquisition, Manipal said it will expand its presence in western India, in line with its strategy to augment its pan-India footprint. "With the strong partnership of our valued stakeholders like Temasek and our other investors, we are excited to grow our operations and bring Manipal's trusted brand of quality healthcare to many more patients," Manipal Health Enterprises MD and CEO Dilip Jose said. Manipal Education and Medical Group (MEMG) Chairman Ranjan Pai said the acquisition will strengthen Manipal's presence in western India. "With this expansion, Manipal Hospitals will have a network of approximately 12,000 beds nationwide, solidifying our position as one of the largest hospital chains in India," he added. Manipal Hospitals is backed by Temasek, a global investment company, headquartered in Singapore, with a net portfolio value of around USD 324 billion as of March 31, 2025. A global investor with net assets of USD 266.3 billion as of December 31, 2024, Ontario Teachers' Pension Plan Board (Ontario Teachers') acquired a majority stake in Sahyadri in 2022. The Pune-based hospital chain is now one of Maharashtra's largest, with 11 hospitals and over 1,400 beds.
